Effect of Nationwide Reimbursement of Real-time Continuous Glucose Monitoring on HbA1c, Hypoglycemia and Quality of Life in a Pediatric Type 1 Diabetes Population: The RESCUE-pediatrics Study

Overview

Journal Front Pediatr

Specialty Pediatrics

Date 2022 Oct 24

PMID 36275049

Authors

Francesca De Ridder

Sara Charleer

Seppe Jacobs

Nancy Bolsens

Kristien J Ledeganck

Sara Van Aken

Jesse Vanbesien

Inge Gies

Kristina Casteels

Guy Massa

Philippe A Lysy

Karl Logghe

Marie-Christine Lebrethon

Sylvia Depoorter

Pieter Gillard

Christophe De Block

Marieke den Brinker

Affiliations

Soon will be listed here.

Abstract

Objective: Real-time continuous glucose monitoring (RT-CGM) can improve metabolic control and quality of life (QoL), but long-term real-world data in children with type 1 diabetes (T1D) are scarce. Over a period of 24 months, we assessed the impact of RT-CGM reimbursement on glycemic control and QoL in children/adolescents with T1D treated with insulin pumps.

Research Design And Methods: We conducted a multicenter prospective observational study. Primary endpoint was the change in HbA1c. Secondary endpoints included change in time in hypoglycemia, QoL, hospitalizations for hypoglycemia and/or ketoacidosis and absenteeism (school for children, work for parents).

Results: Between December 2014 and February 2019, 75 children/adolescents were followed for 12 ( = 62) and 24 months ( = 50). Baseline HbA1c was 7.2 ± 0.7% (55 ± 8mmol/mol) compared to 7.1 ± 0.8% (54 ± 9mmol/mol) at 24 months ( = 1.0). Participants with a baseline HbA1c ≥ 7.5% ( = 27, mean 8.0 ± 0.3%; 64 ± 3mmol/mol) showed an improvement at 4 months (7.6 ± 0.7%; 60 ± 8mmol/mol; = 0.009) and at 8 months (7.5 ± 0.6%; 58 ± 7mmol/mol; = 0.006), but not anymore thereafter (endpoint 24 months: 7.7 ± 0.9%; 61 ± 10mmol/mol; = 0.2). Time in hypoglycemia did not change over time. QoL for parents and children remained stable. Need for assistance by ambulance due to hypoglycemia reduced from 8 to zero times per 100 patient-years (p = 0.02) and work absenteeism for parents decreased from 411 to 214 days per 100 patient-years ( = 0.03), after 24 months.

Conclusion: RT-CGM in pump-treated children/adolescents with T1D showed a temporary improvement in HbA1c in participants with a baseline HbA1c ≥ 7.5%, without increasing time in hypoglycemia. QoL was not affected. Importantly, RT-CGM reduced the need for assistance by ambulance due to hypoglycemia and reduced work absenteeism for parents after 24 months.

Clinical Trial Registration: [ClinicalTrials.gov], identifier [NCT02601729].

Citing Articles

International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024 Diabetes Technologies: Glucose Monitoring.

Tauschman M, Cardona-Hernandez R, DeSalvo D, Hood K, Laptev D, Lindholm Olinder A Horm Res Paediatr. 2025; 97(6):615-635.

PMID: 39884260 PMC: 11854985. DOI: 10.1159/000543156.

Individualized selection of recent glucose monitoring devices for self-management based on competitive features.

Krylova O, Marchenko S, Ermolaeva A, Shustikova N, Dyakonova K Pak J Med Sci. 2024; 40(8):1853-1859.

PMID: 39281234 PMC: 11395364. DOI: 10.12669/pjms.40.8.9855.

Evaluation of newly-developed glycated hemoglobin clinical analytic reagents and chromatography column on Tosoh HLC-723 G8 Analyzer.

Yuan B, Yang W, Zhang N, Shi H, Dong S Pract Lab Med. 2023; 37:e00338.

PMID: 37860220 PMC: 10582560. DOI: 10.1016/j.plabm.2023.e00338.

References

Skinner T, Hoey H, McGee H, Skovlund S . A short form of the Diabetes Quality of Life for Youth questionnaire: exploratory and confirmatory analysis in a sample of 2,077 young people with type 1 diabetes mellitus. Diabetologia. 2006; 49(4):621-8. DOI: 10.1007/s00125-005-0124-0. View

. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA. 2003; 290(16):2159-67. PMC: 2622725. DOI: 10.1001/jama.290.16.2159. View

Breton M, Kanapka L, Beck R, Ekhlaspour L, Forlenza G, Cengiz E . A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes. N Engl J Med. 2020; 383(9):836-845. PMC: 7920146. DOI: 10.1056/NEJMoa2004736. View

Ruedy K, Tamborlane W . The landmark JDRF continuous glucose monitoring randomized trials: a look back at the accumulated evidence. J Cardiovasc Transl Res. 2012; 5(4):380-7. DOI: 10.1007/s12265-012-9364-9. View

Patterson C, Karuranga S, Salpea P, Saeedi P, Dahlquist G, Soltesz G . Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019; 157:107842. DOI: 10.1016/j.diabres.2019.107842. View

Massa G, Gys I, Bevilacqua E, Wijnands A, Zeevaert R . Comparison of flash glucose monitoring with real time continuous glucose monitoring in children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion. Diabetes Res Clin Pract. 2019; 152:111-118. DOI: 10.1016/j.diabres.2019.05.015. View

Isganaitis E, Raghinaru D, Ambler-Osborn L, Pinsker J, Buckingham B, Wadwa R . Closed-Loop Insulin Therapy Improves Glycemic Control in Adolescents and Young Adults: Outcomes from the International Diabetes Closed-Loop Trial. Diabetes Technol Ther. 2020; 23(5):342-349. PMC: 8080922. DOI: 10.1089/dia.2020.0572. View

Slover R, Welsh J, Criego A, Weinzimer S, Willi S, Wood M . Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study. Pediatr Diabetes. 2011; 13(1):6-11. DOI: 10.1111/j.1399-5448.2011.00793.x. View

Charleer S, De Block C, Nobels F, Radermecker R, Lowyck I, Mullens A . Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study. Diabetes Care. 2020; 43(12):3016-3023. DOI: 10.2337/dc20-1531. View

10.

Bergenstal R, Tamborlane W, Ahmann A, Buse J, Dailey G, Davis S . Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010; 363(4):311-20. DOI: 10.1056/NEJMoa1002853. View

11.

Suput Omladic J, Slana Ozimic A, Vovk A, Suput D, Repovs G, Dovc K . Acute Hyperglycemia and Spatial Working Memory in Adolescents With Type 1 Diabetes. Diabetes Care. 2020; 43(8):1941-1944. PMC: 7372055. DOI: 10.2337/dc20-0171. View

12.

Frontino G, Bonfanti R, Scaramuzza A, Rabbone I, Meschi F, Rigamonti A . Sensor-augmented pump therapy in very young children with type 1 diabetes: an efficacy and feasibility observational study. Diabetes Technol Ther. 2012; 14(9):762-4. DOI: 10.1089/dia.2012.0044. View

13.

Gomez A, Umpierrez G . Continuous glucose monitoring in insulin-treated patients in non-ICU settings. J Diabetes Sci Technol. 2014; 8(5):930-6. PMC: 4455384. DOI: 10.1177/1932296814546025. View

14.

Zhong A, Choudhary P, McMahon C, Agrawal P, Welsh J, Cordero T . Effectiveness of Automated Insulin Management Features of the MiniMed 640G Sensor-Augmented Insulin Pump. Diabetes Technol Ther. 2016; 18(10):657-663. PMC: 5111481. DOI: 10.1089/dia.2016.0216. View

15.

Gawel W, Deja G, Kaminska H, Tabor A, Skala-Zamorowska E, Jarosz-Chobot P . How does a predictive low glucose suspend (PLGS) system tackle pediatric lifespan challenges in diabetes treatment? Real world data analysis. Pediatr Diabetes. 2019; 21(2):280-287. DOI: 10.1111/pedi.12944. View

16.

Gurnurkar S, Owens L, Chalise S, Vyas N . Evaluation of Hemoglobin A1c before and after initiation of continuous glucose monitoring in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2021; 34(3):311-317. DOI: 10.1515/jpem-2020-0587. View

17.

Battelino T, Nimri R, Dovc K, Phillip M, Bratina N . Prevention of Hypoglycemia With Predictive Low Glucose Insulin Suspension in Children With Type 1 Diabetes: A Randomized Controlled Trial. Diabetes Care. 2017; 40(6):764-770. DOI: 10.2337/dc16-2584. View

18.

Charleer S, Mathieu C, Nobels F, De Block C, Radermecker R, Hermans M . Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study. J Clin Endocrinol Metab. 2018; 103(3):1224-1232. DOI: 10.1210/jc.2017-02498. View

19.

Hoey H, McGee H, Fitzgerald M, Mortensen H, Hougaard P, Lynggaard H . Parent and health professional perspectives in the management of adolescents with diabetes: development of assessment instruments for international studies. Qual Life Res. 2006; 15(6):1033-42. DOI: 10.1007/s11136-006-0042-8. View

20.

Scaramuzza A, Iafusco D, Rabbone I, Bonfanti R, Lombardo F, Schiaffini R . Use of integrated real-time continuous glucose monitoring/insulin pump system in children and adolescents with type 1 diabetes: a 3-year follow-up study. Diabetes Technol Ther. 2011; 13(2):99-103. DOI: 10.1089/dia.2010.0119. View